General University Hospital, Prague

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Activity

Recent Activity

Last 14 days

Sep 11, 2026

Active, not recruiting

Clinical Observation of the Effect of Ursodeoxycholic Acid on Parameters Affecting Liver, Metabolic and Cardiovascular Morbidity and Mortality - Pilot Project

Sep 11, 2026

Recruiting

Complex Lifestyle Modification in the Treatment of Non-alcoholic Fatty Liver Disease

Earlier

Jul 29, 2026TrialBone Marrow Adipose Tissue as a New Parameter in Relation to Bone and Energy Metabolism in Obesity and Type 2 Diabetes Mellitus

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)